Treatment of cultured cells with brefeldin A (BFA) induces the formation of extensive membrane tubules from the Golgi apparatus, trans-Golgi network, and early endosomes in a microtubuledependent manner. We have reconstituted this transport process in vitro using Xenopus egg cytosol and a rat liver Golgi-enriched membrane fraction. The presence of BFA results in the formation of an intricate, interconnected tubular membrane network, a process that, as in vivo, is inhibited by nocodazole, the H1 anti-kinesin monoclonal antibody, and by membrane pretreatment with guanosine 5Ј-O-(3-thiotriphosphate). Surprisingly, membrane tubule formation is not due to the action of conventional kinesin or any of the other motors implicated in Golgi membrane dynamics. Two candidate motors of ϳ100 and ϳ130 kDa have been identified using the H1 antibody, both of which exhibit motor properties in a biochemical assay. Finally, BFA-induced membrane tubule formation does not occur in metaphase cytosol, and because membrane binding of both candidate motors is not altered after incubation in metaphase compared with interphase cytosol, these results suggest that either the ATPase or microtubule-binding activity of the relevant motor is cell cycle regulated.
INTRODUCTION
Microtubules, and their associated motor proteins, play a central role in maintaining the spatial organization of the secretory and endocytic pathways (reviewed in Lane and Allan, 1998) . Furthermore, microtubule motors are involved not only in the maintenance of organelle structure but also in facilitating the tubovesicular transport of membrane and protein between organelles. Some of these transport steps are conveniently emphasized by treating cultured cells with the fungal metabolite brefeldin A (BFA). Under these conditions the Golgi apparatus very quickly forms membrane tubules, which move along microtubules and fuse with the endoplasmic reticulum (ER), resulting in a dramatic redistribution of Golgi apparatus components into the ER and the loss of the Golgi apparatus as a discrete organelle (Lippincott-Schwartz et al., 1990) , and it has been suggested that this represents an enhanced version of the normal Golgi-to-ER transport process Lippincott-Schwartz, 1993) . The formation of BFA-induced Golgi tubules has been shown to be dependent on microtubule motor activity, because it is inhibited by the microinjection of the H1 monoclonal antibody (Lippincott-Schwartz et al., 1995) , which was raised against the plus end-directed motor kinesin from bovine brain (Bloom et al., 1988; Hirokawa et al., 1989; Elluru et al., 1995) .
BFA also causes microtubule-dependent tubule extension and redistribution of both the trans-Golgi network (TGN) and early endosomes Wood et al., 1991; Reaves and Banting, 1992) . The TGN tubules do not appear to fuse with the ER but instead fuse with the early endosomal network. The suppression of conventional/ubiquitous kinesin heavy chain (uKHC) expression using an antisense approach inhibited the formation of tubules containing either mannose-6-phosphate receptor (an endosomal and TGN marker) or the fluid phase endocytic marker lucifer yellow, suggesting that uKHC may be the motor that drives the outward movement of TGN and endosomal BFA tubules (Feiguin et al., 1994) . Interestingly, the same treatment did not inhibit the BFA-induced redistribution of Golgi enzymes into the ER (Feiguin et al., 1994) , in seeming contradiction to the results of Lippincott-Schwartz et al. (1995) .
To study the properties of the motor proteins involved in BFA-induced membrane tubule formation more closely, we have developed an in vitro assay combining a rat liver Golgi-enriched membrane preparation with Xenopus egg cytosol. Such cytosols are ideal for studying microtubuledriven membrane movement, because they polymerise microtubules and support membrane motility at room temperature, and furthermore, the cell cycle state of these extracts is relatively easy to manipulate (Allan, 1993) . It has previously been shown that interphase cytosols support the microtubule-dependent formation of Xenopus-derived ER networks and the movement of small vesicles, whereas metaphase cytosols do not (Allan and Vale, 1991 ; reviewed in Robertson and Allan, 1997) . In metaphase, cytoplasmic dynein-driven membrane movement is thought to be inactivated by the phosphorylation of cytoplasmic dynein light intermediate chains, which correlates with detachment of cytoplasmic dynein from the membrane (Niclas et al., 1996) . In addition, interphase, but not metaphase, cytosol has been shown to support the movement of membranes purified from rat liver Vale, 1991, 1994) . Because membrane traffic is generally inhibited as cells enter mitosis (reviewed in Warren, 1985) , it would be of interest to determine whether the effect of BFA on membrane dynamics is also cell cycle regulated.
In this study we have reconstituted BFA-induced membrane tubule formation in vitro. This tubule extension is driven by microtubule motor activity and is inhibited by the H1 monoclonal anti-kinesin antibody. Surprisingly, this movement was not generated by the action of conventional kinesin. Instead, H1 recognized two proteins that behaved like kinesin-like proteins (KLPs) but were distinct from conventional kinesin or any of the other motor proteins currently implicated in Golgi membrane dynamics. Finally, BFA-induced membrane tubule formation does not occur in metaphase cytosol, demonstrating that the motor involved is cell cycle regulated.
MATERIALS AND METHODS

Materials
Antibodies and other reagents were generously provided by the following people: H1 monoclonal antibody (mAb) from Dr. G. Bloom (University of Texas Southwestern Medical Center, Dallas, TX); SUK 4 hybridoma (Ingold et al., 1988) from Dr. J. Scholey (University of California, Davis, CA); rabbit anti-Rabkinesin 6 (Echard et al., 1998) from Dr. B. Goud (Institut Curie, Paris, France); rabbit anti-KIF1C (Dorner et al., 1998) from Dr. R. Lammers (Max-Planck Institut fü r Biochemie, Martinsried, Germany); rabbit anti-uKHC, affinity-purified rabbit anti-neuronal kinesin heavy chain (nKHC) (Niclas et al., 1994) , and bovine brain tubulin from Dr. R. Vale (University of California, San Francisco, CA); bacterially expressed rat kinesin heavy chain head domain from Dr. R. Cross (Marie Curie Research Institute, Oxted, Surrey, United Kingdom); rabbit anti-HIPYR and anti-LAGSE (originally raised by Dr. T. Mitchison and coworkers; Sawin et al., 1992) and monoclonal antikinesin II (85-kDa subunit: originally raised by Dr. J. Scholey; Cole et al., 1993) from Dr. V. Gelfand (University of Illinois, Urbana, IL); maD, which recognizes ␤-coatomer protein (␤-COP) (Pepperkok et al., 1993) , from Dr. T. Kreis, (University of Geneva, Geneva, Switzerland); rabbit anti-GM130 (Nakamura et al., 1995) and anti-giantin from Dr. G. Warren (Imperial Cancer Research Fund, London, United Kingdom); rabbit anti-TGN38 (Luzio et al., 1990) from Dr. P. Luzio (University of Cambridge, Cambridge, United Kingdom); and 1D3, which recognizes a KDEL-containing peptide (Vaux et al., 1990) , from Dr. D. Vaux (University of Oxford, Oxford, United Kingdom). Monoclonal H68.4 against human transferrin receptor was obtained from Zymed (San Francisco, CA), and sheep anti-rat albumin was from Cappel/Organon Teknika (Turnhout, Belgium). BFA and Taxol (paclitaxel) were purchased from LC Laboratories (Nottingham, United Kingdom). Sucrose (ultrapure grade) was purchased from Life Technologies (Paisley, United Kingdom). Unless otherwise stated, all other reagents were purchased from Sigma (Poole, Dorset, United Kingdom) or BDH (Poole, Dorset, United Kingdom).
Preparation of Xenopus Egg Cytosols and the Rat Liver Golgi Membrane Fraction
Concentrated interphase-and metaphase-arrested Xenopus egg extracts were prepared and analyzed for cell cycle status as described previously (Allan and Vale, 1991; Allan, 1993 Allan, , 1998 Lane and Allan, 1999) . High-speed cytosols were then prepared by diluting the extracts with 2 vol of acetate buffer (100 mM K-acetate, 3 mM Mg-acetate, 5 mM EGTA, 10 mM HEPES, pH 7.4) containing 150 mM sucrose, 7.5 mM creatine phosphate, and 1 mM MgATP, and then spinning at 55,000 rpm (117,000 ϫ g av ), for 30 min at 4°C, in a TLA100 rotor (Beckman, High Wycombe, Bucks, United Kingdom). These cytosolic fractions were used to study BFA-induced membrane tubule movement (see RESULTS). To compare this novel motility with the previously observed "ball-domain" tubule motility (Allan and Vale, 1994) , high-speed supernatants were also prepared from extracts made by crushing dejellied eggs in 1.5 vol of acetate buffer (for details, see Allan and Vale, 1994) .
A Golgi-enriched membrane fraction (protein concentration ϳ4.0 mg/ml) was prepared from rat liver (Leelavathi et al., 1970) , with the modifications described (Allan and Vale, 1991) . More concentrated Golgi membranes (ϳ10 mg/ml) were obtained by collecting only the largest membrane aggregates.
Motility Assays and Microscopy
Motility assays were generally performed as described (Allan and Vale, 1994; Allan, 1998) using 8 l of Xenopus egg cytosol plus 1 l of rat liver Golgi membrane fraction, 0.5 l of BFA (2 mg/ml), and 0.5 l of acetate buffer. The 0.5 l of acetate buffer was substituted with nocodazole (to 4 M), guanosine 5Ј-O-(3-thiotriphosphate) (GTP␥S; to 0.25 mM), or sodium orthovanadate (to 40 M). BFA stock solutions (10 mg/ml in methanol) were stored at Ϫ20°C and diluted to 2 mg/ml in acetate buffer immediately before use. The direction of vesicle movement was assayed using demembranated, salt-washed axoneme fragments from Tetrahymena (Allan and Vale, 1991) . Motility was followed by video-enhanced differential interference contrast microscopy (VE-DIC) in real time using an Olympus Optical (Tokyo, Japan) BX60 microscope equipped with DIC optics (Allan, 1998) . The RETRAC object tracking system (Dr. N. Carter, Marie Curie Research Institute, Oxted, Surrey, United Kingdom) was used to determine rates of movement from videotape sequences and to digitize single frames. To analyze the extent of membrane tubule formation under each incubation condition, the membrane networks were traced directly onto acetate sheets, and tubule length was determined using a map measuring tool.
Antibody inhibition studies were carried out as follows: rat liver Golgi membranes were preincubated on ice with either the H1 ascites or a control c-myc ascites for 25 min at a 5:1 ratio. Alternatively, Golgi membranes were preincubated on ice with either the SUK 4 monoclonal antibody (Ingold et al., 1988 ; ϳ5 mg/ml in PBS [140 mM NaCl, 2.7 mM KCl, 1.5 mM KH 2 PO 4 , 8.1 mM Na 2 HPO 4 ]) or a control purified mouse immunoglobulin G (IgG; 5 mg/ml in PBS) for 45 min at a 4:1 ratio. The membranes were then used in motility assays as described above. The presence of ascites often reduced microtubule polymerization (for unknown reasons), which was countered by pretreating the perfusion chambers with cytosol (diluted 1:5 with acetate buffer) containing 100 g/ml BFA for 5 min. When analyzing the effect of GTP␥S on motility, 0.25 mM GTP␥S was added to rat liver Golgi membranes in interphase cytosol for 5 min at room temperature (RT) and then 10 min on ice, followed by the addition of 100 g/ml BFA, or membranes and cytosol were incubated with BFA for 5 min at RT and then 10 min on ice before the addition of GTP␥S.
Immunofluorescence analysis of the BFA-induced membrane networks and ball-domain networks assembled for 40 -45 min was performed as described (Allan and Vale, 1994) except that 0.5% (wt/vol) tannic acid in acetate sucrose buffer was flowed through the chamber to stabilize the membrane tubules, instead of flowing through buffer containing fixative. The coverslips were then fixed in methanol and processed for immunofluorescence (Allan and Vale, 1994) . Primary antibody dilutions were as follows: anti-giantin, 1:500; anti-albumin, 1:1000; anti-transferrin receptor, 1:100; and anti-TGN38, 1:400. Alexa 488-and Alexa 594-conjugated (Molecular Probes, Leiden, The Netherlands) and Texas Red-conjugated (Jackson ImmunoResearch, West Grove, PA) secondary antibodies were used at 1:200 or 1:400. Images were obtained using an Olympus BX-60 microscope with a UplanFl 100 ϫ 1.30 numerical aperture Pol objective and appropriate filter sets, coupled to a MicroMax slowscan, cooled charge-coupled device camera (Roper Scientific, Marlow, Bucks, United Kingdom) driven by MetaMorph software (Universal Imaging, West Chester, PA).
Microtubule Binding and ATP Release of Motor Proteins
Microtubules were polymerized from purified bovine brain tubulin as described (Vale and Toyoshima, 1988) , stabilized with 20 M Taxol, and stored at Ϫ80°C. For each microtubule binding/ATP release assay, rat liver Golgi membranes (125 l) were made up to 10 U/ml hexokinase, 20 M glucose, 20 M Taxol, 400 M 5Ј-adenylyl imidodiphosphate (AMP.PNP), 0.5% Triton TX-100 (Surfact-Amps X-100; Pierce, Chester, United Kingdom), 1 mM DTT, 10 g/ml protease inhibitors (leupeptin, chymostatin, pepstatin, and aprotinin), and 1 g/ml cytochalasin D, and were incubated for 5 min at RT. Finally, Taxol-stabilized microtubules were added to 0.13 mg/ml, and the mixture was incubated at RT for 30 min. The mixture was then layered onto a cushion of 40% sucrose in BRB80 (80 mM 1,4-piperazinediethanesulfonic acid, 2 mM MgCl 2 , 1 mM EGTA, pH 7.4 with KOH) containing 1 mM DTT, 1 g/ml cytochalasin D, 2.5 g/ml protease inhibitors, and 4 M Taxol, and the microtubules were recovered by spinning at 68,000 ϫ g av for 20 min at 22°C in a TLS55 rotor (Beckman). The proteins in the supernatant and cushion were recovered by chloroform/methanol precipitation (Wessel and Flugge, 1984) and prepared for SDS-PAGE and immunoblotting. The microtubule pellets were resuspended in 12.5 l of BRB80 containing 5 mM MgATP, 1 mM DTT, 10 g/ml protease inhibitors, and 10 g/ml cytochalasin D and were incubated at RT for 25 min. Microtubules were then separated from the ATP release supernatant by spinning for 15 min at 68,000 ϫ g av in the TLS55 rotor. The entire microtubule pellet fraction was loaded into a single SDS-PAGE gel lane, as were all other fractions. Essentially the same protocol was followed for microtubule binding/ATP release studies carried out under high-salt conditions, except that KCl was substituted with 0.5 M NaCl, and as a control, ATP was substituted with 5 mM AMP.PNP.
When a more concentrated preparation of microtubule motors was required, 300 l of concentrated rat liver Golgi membranes (protein concentration ϳ10 mg/ml) were solubilized and incubated under the motor binding conditions detailed above, but with microtubules added to 0.6 mg/ml rather than 0.13 mg/ml.
Immunoprecipitation of uKHC from Golgi Membrane Fractions
Two batches of Protein G beads (Zymed; 100-l slurry per tube) were blocked by incubation in 20% BSA in PBS for 30 min at 4°C, with constant rotation. One set of beads was incubated with 126 g of SUK 4, the other with purified mouse IgG, overnight at 4°C with constant rotation. Beads were then washed with PBS and resuspended in 400 l of rat liver Golgi membranes, which had been solubilized with 1% Triton X-100, and incubated for 2 h on ice, with occasional agitation. The beads were washed four times with PBS and resupended in 2ϫ Laemmli sample buffer.
Analysis of ␤-COP Membrane Binding after BFA and GTP␥S Treatment
Rat liver Golgi membranes (20 l) were incubated with 112.5 l of interphase cytosol plus one of the following: 1) 1.5 l of methanol and 6 l of acetate buffer; 2) 1.5 l of BFA (from the 10 mg/ml methanol stock) and 6 l of acetate buffer; 3) 6.0 l of GTP␥S (to 0.25 mM) for 5 min and then 1.5 l of BFA; and 4) 1.5 l of BFA for 5 min and then 6 l of GTP␥S (to 0.25 mM). Samples were incubated at RT for 30 min, then on ice for 15 min, and were then diluted with 200 l of acetate buffer (containing 1 mM DTT and 1 g/ml protease inhibitors). Membranes were recovered by spinning at 100,000 ϫ g av in a TLS55 rotor, through a cushion of 400 mM sucrose in acetate buffer, at 4°C.
Analysis of Motor and Membrane Binding in Interphase and Metaphase Cytosols
Thirty microliters of rat liver Golgi membranes were incubated in 120 l of acetate buffer or in interphase or metaphase cytosol (prepared using 2 vol of acetate buffer without sucrose) for 45 min at RT, followed by 15 min on ice to depolymerise microtubules. Each mixture was then diluted with 500 l of acetate buffer (containing 1 mM DTT and 1 g/ml protease inhibitors) and layered onto a 400 mM sucrose/acetate buffer cushion (containing 1 mM DTT and 1 g/ml protease inhibitors). Membranes were recovered by spinning at 100,000 ϫ g av in a TLS55 rotor for 30 min at 4°C.
PAGE and Immunoblotting
Electrophoresis and immunoblotting were performed as described (Lane and Allan, 1999) . Primary antibody dilutions used were: H1 mAb, 1:500; MaD anti-␤-COP, 1:2000; rabbit anti-uKHC, 1:4000; affinity-purified rabbit anti-nKHC, 1:300; rabbit anti-HIPYR, anti-LAGSE, anti-Rabkinesin 6, and anti-KIF1C, 1:500; and rabbit anti-GM130, 1:3000. After incubation with horseradish peroxidase-conjugated (Pierce) or alkaline phosphatase-conjugated (Jackson ImmunoResearch) secondary antibodies, blots were developed using the ECL SuperSignal detection kit (Pierce) and exposed to Eastman Kodak (Rochester, NY) X-OMAT LS film or using an alkaline phosphatase nitro blue tetrazolium/5-bromo-4-chloro-3-indolyl phosphate color reaction. Blots were scanned into Adobe (Mountain View, CA) Photoshop using a Sharp (Mahwah, NJ) JX-330 scanner. The public domain NIH image program (developed at the US National Institutes of Health and available on the internet at http://rsb.info.nih.gov/nih-image/) was used for analysis of band intensity on an Apple (Cupertino, CA) Macintosh Power PC.
RESULTS
BFA-induced Membrane Tubule Formation Reconstituted In Vitro Is a Plus End-directed Microtubule Motor-dependent Process
The assay system used in these studies uses a combination of Xenopus egg cytosol and a rat liver Golgi membrane fraction that contains stacked and single cisternae, together with large vesicles containing very-low-density lipoprotein particles Vale, 1991, 1994) . When these membranes were incubated in interphase high-speed supernatant, without BFA, we observed two classes of structures. The first type consisted of a population of highly motile vesicles ( Figure 1A , left panel, open arrowheads), which moved toward microtubule plus ends at 1.24 Ϯ 0.03 m/s (n ϭ 21; Table 1 ). Vesicle movement remained exclusively plus end directed in the presence of BFA but occurred at a slightly slower rate (1.00 Ϯ 0.04 m/s; n ϭ 20; Table 1 ) than in the absence of the drug. The second population of membranes consisted of large, nonmotile clumps ( Figure 1A , left panel, open arrow), which only occasionally formed membrane tubules ( Figure 1A , left panel, closed arrow). However, when 100 g/ml BFA was included in the assay, membrane tubules extended out from these clumps within 5 min, and by 30 -60 min an intricate tubular membrane network resulted ( Figure 1A , right panel, and Table 2 ). The maximal amount of membrane tubule formation was seen at 100 g/ml BFA, although a significant amount was observed at concentrations as low as 5 g/ml (Robertson and Allan, unpublished data).
The membrane network extension was dependent on the presence of microtubules (Table 2) , and careful observation of 196 membrane tubule movements revealed that all were driven by membrane-associated motor protein activity and not by static membrane attachment (via tip attchment complexes) to growing or gliding microtubules (Vale and Hotani, 1988; Waterman-Storer et al., 1995) . The membrane tubules translocated along microtubules at a rate of 0.25 Ϯ 0.06 m/s (n ϭ 20) and were determined to be exclusively plus end directed (n ϭ 65; Table 1 ) by comparison with the direction of vesicle movement movement (known to be 100% plus end directed; Table 1 ) along the same microtubule.
Because BFA induces tubule formation from the Golgi apparatus, TGN and early endosomes (Lippincott-Schwartz et al., 1989 , 1991 Wood et al., 1991; Sciaky et al., 1997) , and in some cases late endosomes and lysosomes , we used an immunofluorescence (B) Microtubule motor activity of BFA-induced membrane tubules. A sequence of VE-DIC images taken at 5 s intervals shows a typical BFA-induced membrane tubule (arrow) moving along a microtubule (arrowhead). Note that the moving membrane tubule tip does not possess the characteristic globular domain seen in previous studies using different cytosol (Allan and Vale, 1994) . Bar, 5 m (applies to all three panels).
approach (Allan and Vale, 1994 , modified as described in MATERIALS AND METHODS) to identify the membrane networks formed in vitro from the rat liver Golgi fraction. The membrane tubules contained the secretory protein albumin (Figure 2A ), as well as the Golgi resident protein giantin (Linstedt and Hauri, 1993) . Surprisingly, the networks also labeled with antibodies to TGN38 ( Figure 2CЈ ) and to the early endosomal marker transferrin receptor ( Figure 2C ), both of which colocalized almost completely with giantin ( Figure 2BЈ ; Allan, unpublished data) and with each other (Figure 2 , C and CЈ). These results suggest that BFA has induced fusion between elements of the Golgi apparatus, TGN, and early endosomes (see DISCUSSION). However, lysosomes remained as distinct, single organelles (Allan, unpublished data) , which demonstrates that indiscriminate fusion is not occurring.
A key questions raised by these results is how these BFA-induced networks relate to the membrane networks we have previously observed forming in the absence of BFA from the same rat liver Golgi membrane fraction when incubated in Xenopus egg cytosol prepared using a different protocol Vale, 1991, 1994) . These latter membrane tubules had a characteristic morphology, with ϳ90% of moving tubule tips possessing a distinct globular domain (Allan and Vale, 1994) , whereas only 11% (n ϭ 90) of the moving tips of BFA-induced membrane tubules described here had a similar "ball-like" structure, with 89% being smooth at their tips ( Figure 1B) . Moreover, the rate of BFAinduced tubule formation reported here (Table 1) is approximately four times slower than that of the ball-domain tubules, which translocate at 1.13 Ϯ 0.1 m/s (n ϭ 20).
However, the clearest evidence for the two types of networks being absolutely distinct has been obtained using our improved immunofluorescence method. Although the balldomain tubules contain albumin ( Figure 2D ), just like the BFA networks (Figure 2A ), the ball-domain tubules do not contain detectable giantin ( Figure 2DЈ ), transferrin receptor, or TGN38 (Allan, unpublished data) . In addition, because the ball-domain tubules label with an accepted ER marker (1D3, which was raised against a KDEL-containing peptide; Vaux et al., 1990;  Figure 2E ), these tubules may be formed from smooth ER membranes that are present in the rat liver Golgi fraction or, alternatively, may be derived from intermediate compartment membranes, which would be expected to contain recycling ER markers.
Taken together, these data provide strong evidence that the two networks are functionally and morphologically distinct. It is currently unclear why cytosols prepared using different protocols should promote such distinct types of membrane tubule movement.
The BFA Effect Is Inhibited by the Preaddition of GTP␥S
Because the in vitro assay was reconstituting at least one of BFA's in vivo effects, the formation of membrane tubules, we next wanted to determine whether BFA was also disrupting the function of coatomer proteins in vitro. BFA prevents the activation of ADP ribosylation factor 1, which is a small GTP-dependent protein required for membrane traffic through the Golgi apparatus  The length of membrane tubules present per field (micrometers) was determined for 25 fields after a 10-and 60-min incubation, and the average values are expressed Ϯ SEM.
BFA-induced Membrane Tubule Motility Helms and Rothman, 1992) . ADP ribosylation factor is recruited to the Golgi membrane when it is in its GTP-bound form, and it, in turn, recruits the coatomer subunits needed for the formation of COP I-coated vesicles Donaldson et al., 1992; Klausner et al., 1992) . Because BFAinduced dissociation of coatomer, and therefore membrane tubule formation, is inhibited by pretreatment with the nonhydrolyzable analogue of GTP (GTP␥S) , we predicted that similar results should be observed in vitro. Rat liver Golgi membranes in interphase Xenopus egg cytosol were treated with 0.25 mM GTP␥S for 5 min at room temperature, followed by 10 min on ice, either before or after the addition of 100 g/ml BFA. These samples were then flowed into the microscope perfusion chambers and observed by VE-DIC microscopy. Pretreatment of the membranes with GTP␥S resulted in a dramatic inhibition of membrane tubule formation in the presence of BFA ( Figure  3A) . In contrast, when the membranes were incubated with GTP␥S after BFA addition, no inhibition of membrane tubule formation was apparent after 10 min in the flow chamber ( Figure 3A ), and only a limited inhibition was observed after 60 min ( Figure 3A) . These results suggest that GTP␥S does not have a direct effect on BFA tubule motor activity. This is in contrast to the movement of ball-domain tubules, which was completely inhibited (no movements observed during 30 min) by incubation with 0.25 mM GTP␥S in the presence or absence of BFA.
The effect of treating the membranes with GTP␥S and BFA was then correlated with its effect on the membrane binding of ␤-COP, a component of the COP I coatomer complex ( Figure 3B ). Immunoblotting of rat liver Golgi membranes incubated in buffer alone revealed that rat ␤-COP is recognized as a single band (lane 5). When membranes were incubated in interphase Xenopus egg cytosol (see MATERI-ALS AND METHODS), an additional band was detected by the anti-␤-COP antibody, corresponding to Xenopus ␤-COP that had been recruited to the membrane (lane 1). If BFA was present during the incubation with cytosol, less ␤-COP (both rat and Xenopus) was detected in the membrane pellet (lane 2). However, when membranes and cytosol were preincubated with GTP␥S for 5 min before addition of BFA, the amount of membrane-associated ␤-COP was greatly increased (lane 3). This was not seen if GTP␥S was added after BFA (lane 4).
From these results it is clear that in our in vitro assay BFA is having the expected effect on ␤-COP recruitment, and moreover, that stimulating coatomer recruitment by adding GTP␥S was correlated with the prevention of membrane tubule movement and extension.
BFA-induced Membrane Tubule Formation Is Inhibited by the H1 Monoclonal Antibody
Having demonstrated that BFA-induced membrane tubule formation is due to microtubule motor activity, an antibody inhibition approach was used to identify candidate motors. The H1 anti-kinesin monoclonal antibody has previously been shown to inhibit BFA-dependent Golgi redistribution in vivo (Lippincott-Schwartz et al., 1995) and was therefore the most obvious candidate to block motor function in this assay. Immunofluorescence analysis of BFA-induced membrane tubules and ball-domain tubules demonstrates that they contain distinct organelle markers. Networks formed in the presence of 100 g/ml BFA (A-C and AЈ-CЈ) were processed for double-labeling immunofluorescence (see MATERIALS AND METHODS). The membrane tubules label with antibodies to the secretory marker rat albumin (A), the Golgi stack protein giantin (AЈ and BЈ), TGN38 (CЈ), and transferrin receptor (B and C), demonstrating that fusion has occurred between elements of the Golgi apparatus, TGN, and early endosomes. A different class of membrane tubule, ball-domain tubules, assemble in the absence of BFA when the rat liver Golgi fraction is incubated with Xenopus egg cytosol prepared by a different method (Allan and Vale, 1994 ; see MATERIALS AND METHODS). Unlike BFA tubules, the ball-domain tubules do not contain giantin (DЈ and EЈ) but do label with antibodies against rat albumin (D) and the mAb 1D3 (E), which recognizes KEDL-containing proteins in the ER. Bar, 5 m (applies to all panels).
Membranes were preincubated with H1 ascites or with a control anti-c-myc ascites for 20 min, as described in MATE-RIALS AND METHODS, and then added to untreated interphase cytosol. Membrane tubule formation was shown to be almost totally inhibited by pretreatment of the membrane with H1 ( Figure 4A ). Interestingly, H1 treatment had no effect on the amount of vesicle movement observed (Robertson and Allan, unpublished data), which, taken together with the different rates of tubule and vesicle movement, strongly suggested that the two types of translocation involved different plus end-directed motors.
We then repeated the above experiment using a different function-blocking anti-kinesin antibody, SUK 4 (Ingold et al., 1988) . Surprisingly, pretreatment of Golgi membranes with Figure 4B ), even in cytosol that had been immunodepleted of kinesin (Robertson and Allan, unpublished data) . The same preparation of SUK 4, used at the same dilution, effectively inhibited plus end-directed ER tubule extensions in vitro (Lane and Allan, 1999) , demonstrating that our antibody preparation was functional.
Ubiquitous Kinesin Heavy Chain Is Not the Motor Involved in BFA-induced Membrane Tubule Formation
The apparent conflict between the results obtained after H1 and SUK 4 anti-kinesin antibody treatments led us to investigate which polypeptides the antibodies were recognizing in Xenopus egg cytosol and the rat liver Golgi fraction. We have previously shown that SUK 4 recognizes Xenopus egg kinesin (Lane and Allan, 1999) . Although the SUK 4 antibody did not recognize any polypeptides by immunoblotting of the Golgi membranes (Robertson and Allan, unpublished data) , it did immunoprecipitate conventional uKHC efficiently from solubilized membranes ( Figure 5A , lane 1), as detected using a polyclonal antibody to uKHC (Niclas et al., 1994) .
H1 is known to recognize bovine brain KHC and labels purified bacterially expressed rat uKHC head domain by immunoblot (Robertson and Allan, unpublished data) . However, H1 did not recognize Xenopus uKHC but instead detected only a polypeptide of ϳ70 kDa in Xenopus egg extracts ( Figure 5B , lane 4) that was unable to bind to microtubules (lanes 5 and 6), making this protein an unlikely candidate for the motor involved in driving membrane tubule formation. In addition, H1 only inhibited tubule extension when it was preincubated with membranes ( Figure 4A ) and not when it was added first to the cytosol (Robertson and Allan, unpublished data). The ϳ70-kDa protein in Xenopus cytosol is therefore likely to be recognized by H1 because of antibody cross-reaction.
Because all the functional evidence pointed to the motor protein being present on the membranes, we investigated which proteins H1 recognized in the Golgi fraction. Surprisingly, H1 revealed not only a band at M r ϳ124,000, which had a mobility similar to that of the polypeptide recognized by a polyclonal anti-uKHC antibody ( Figure 6A , lane 6), but also proteins at M r ϳ130,000 and ϳ100,000 ( Figure 6A , lane 1), although the intensity of the ϳ100-kDa immunoreactive band varied somewhat between preparations. It was therefore necessary to establish whether any of these bands were microtubule motors. One of the characteristic properties of KLPs is that they bind rigorously to microtubules under Figure 5 . H1 does not recognize conventional KHC in rat liver Golgi membranes or in Xenopus egg cytosol. (A) Ubiquitous kinesin immunoprecipitated from solubilized rat liver Golgi membranes using the SUK 4 monoclonal (lanes 1 and 3) was immunoblotted with either polyclonal anti-uKHC (lane 1), which recognized bands at ϳ125 and ϳ250 kDa (probably incompletely dissociated kinesin heavy chains), or H1 (lane 3), which failed to produce a signal. Nonimmune mouse IgG was used as a control (lanes 2 and 4). The bands between 50 and 60 kDa are antibody heavy chains (lanes 3 and 4). (B) Microtubule pellets enriched in motors were prepared from interphase Xenopus egg cytosol and then extracted with 5 mM ATP and 100 mM NaCl to give an ATP release fraction (lanes 3 and 6) and the remaining microtubule pellet (lanes 2 and 5). Interphase cytosol is loaded in lanes 1 and 4. After SDS-PAGE, protein samples were immunoblotted with either the polyclonal anti-uKHC antibody (lanes 1-3) or the H1 monoclonal antibody (lanes 4 -6). Although H1 recognized a band at ϳ70 kDa (lane 4), this polypeptide did not pellet with microtubules, unlike uKHC (compare lanes 2 and 3 with 5 and 6). conditions of ATP depletion, in the presence of the nonhydrolyzable ATP analogue AMP.PNP. This trait was used to establish whether the H1 antigens identified in the Golgi fraction behaved like KLPs in a biochemical assay.
Detergent-solubilized membranes were incubated with microtubules in the presence of AMP.PNP under conditions that cause ATP depletion (see MATERIALS AND METH-ODS) for 25 min at room temperature. The microtubules were then recovered by centrifugation, and the microtubule pellet was carefully resuspended and incubated in buffer containing 5 mM ATP and 100 mM KCl. The microtubules were then separated from the released motor fraction by centrifugation. The resultant microtubule pellet and ATP release supernatant were resolved by SDS-PAGE and immunoblotted with H1 ( Figure 6A, lanes 4 and 5) or the antiuKHC polyclonal antibody ( Figure 6A, lanes 9 and 10) . The proteins that remained in the supernatant and cushion during the first spin were recovered by precipitation (see MA-TERIALS AND METHODS) and analyzed in parallel ( Figure  6A, lanes 2, 3, 7, and 8) .
Immunoblotting revealed, unexpectedly, that the H1 antigen that comigrated with kinesin heavy chain by SDS-PAGE did not associate with microtubules under conditions that promote motor binding (i.e., in the presence of AMP-.PNP and in the absence of ATP) but instead remained in the supernatant ( Figure 6A , lane 2). This band was not detectable in the cushion, microtubule pellet, or ATP release supernatant ( Figure 6A, lanes 3-5) . Kinesin heavy chain, however, detected using a polyclonal anti-uKHC, behaved exactly as expected: it bound to microtubules under motor binding conditions and was partially released upon treatment with ATP and 100 mM KCl ( Figure 6A, lanes 9 and 10) . Moreover, unlike H1, anti-uKHC did not detect any protein in the postmicrotubule supernatant, suggesting that for some reason H1 does not recognize uKHC in the rat liver Golgi membrane fraction. Further strong evidence for this conclusion was obtained by immunoprecipitating kinesin from solubilized membranes using SUK 4 and probing the precipitates with both the polyclonal anti-uKHC and H1 ( Figure 5A, compare lanes 1 and 3) .
Identification of Two Candidate Motor Proteins Using the H1 Monoclonal Antibody
We next turned our attention to the other polypeptides detected by the H1 antibody. Both the M r ϳ130,000 and ϳ100,000 bands did indeed bind to microtubules under motor binding conditions ( Figure 6A , lane 4), but neither protein was released after ATP and 100 mM KCl treatment ( Figure 6A, lane 5) . However, because the microtubule motor protein Eg5 (Sawin et al., 1992) is only fully released from the microtubule pellet under more rigorous salt conditions, we repeated the microtubule binding/ATP release experiment with the ATP release step carried out in the presence of 0.5 M NaCl instead of 100 mM KCl ( Figure 6B, lanes 1 and  2) . As a control, ATP was substituted with AMP.PNP, which should prevent motor protein release under these high-salt conditions ( Figure 6B , lanes 3 and 4; note that very little of the ϳ100-kDa band was detected in this preparation). The ϳ130-kDa antigen was partially released from the microtubule pellet under conditions of high salt and ATP ( Figure 6B , lane 2), and as would be expected from a KLP, this release was prevented when ATP was substituted with AMP.PNP ( Figure 6B, lane 4) .
Another feature that has helped in the identification of a number of KLPs is the fact that antibodies generated to conserved sequences with the motor domain will recoginze a fairly broad range of kinesin family members (e.g., Cole et al., 1992; Sawin et al., 1992) . We therefore immunblotted the Golgi-derived motor fractions with affinity-purified anti-LAGSE and anti-HIPYR (Sawin et al., 1992) , and, as has been observed previously (Sawin et al., 1992) , the polypeptides recognized by each antibody were mostly distinct, with only some being recognized by both reagents (Figure 7, lanes 1  and 2) . The ϳ100-kDa H1 antigen (lane 3) comigrated with a polypeptide labeled by the HIPYR (lane 1, arrow), but not LAGSE (lane 2) antibodies, providing further evidence that it is a member of the kinesin superfamily. There was no clear immunoreactive band in either the HIPYR or LAGSE lanes that comigrated with ϳ130-kDa H1 antigen, although the strength of the signal at ϳ150 kDa in the LAGSE lane could have masked such a signal. It should be stressed that these antibodies, even taken together, do not recognize all KLPs. This is shown clearly by the observation that we could demonstrate the presence of the 85-kDa component of kinesin II using a monoclonal antibody (Figure 7 , lane 4), even though neither HIPYR nor LAGSE antibodies recognized proteins in this size range in the Golgi motor preparation (lanes 1 and 2) .
So far, four kinesin family members have been implicated in Golgi complex membrane dynamics, namely, kinesin heavy chain (Feiguin et al., 1994; Lippincott-Schwartz et al., 1995) , Rabkinesin 6 (Echard et al., 1998) , kinesin II/Xklp3/ KIF3C (Le Yang and Goldstein, 1998) , and KIF1C (Dorner et al., 1998) . Having compiled evidence that the ϳ100-and ϳ130-kDa H1 antigens are motor proteins, it was necessary to establish whether they corresponded to any of these candidate Golgi motors.
Microtubule pellets enriched in Golgi membrane motors were immunoblotted with antibodies against kinesin heavy chain ( Figure 7B, lanes 1 and 3) and KIF1C ( Figure 7B , lane 5), neither of which recognized bands that comigrated with either H1 antigen (Figure 7, A, lane 3, and B, lane 4) . In addition, both antigens are larger than the 85-and 95-kDa kinesin II subunits. It was possible that the ϳ130-kDa H1 antigen was an isoform of KHC, even though all such isoforms described so far are neuronally enriched. However, an affinity-purified antibody against nKHC (Niclas et al., 1994) did not recognize any polypeptides in this Golgi-derived microtubule motor fraction ( Figure 7B, lane 2) .
One obvious candidate of ϳ100 kDa is Rabkinesin 6, but a number of lines of evidence suggest that this protein is not the ϳ100-kDa H1 antigen. First, an antibody against Rabkinesin 6 (Echard et al., 1998) did not recognize any proteins of the appropriate size in the rat liver Golgi membrane or motor fraction by immunoblotting (Robertson and Allan, unpublished data) . Second, inspection of the Rabkinesin 6 sequence (Echard et al., 1998) revealed that anti-LAGSE, but not anti-HIPYR, would be expected to recognize this motor, exactly the reverse of what we found for the H1 antigen. Moreover, neither bacterially nor baculovirally expressed Rabkinesin 6 was labeled by H1 (Goud, personal communication).
Taken together these results indicate that both the ϳ100-and ϳ130-kDa H1 antigens represent motors not previously implicated in the movement of Golgi membranes. Unfortunately, attempts to obtain peptide sequence data from the ϳ130-kDa band have so far been unsuccessful.
BFA-induced Membrane Networks Do Not Form in Metaphase Cytosol
There is considerable evidence that both membrane traffic and many types of organelle movement are inhibited as cells enter metaphase (reviewed in Robertson and Allan, 1997) , and we have previously made use of the Xenopus egg extract system to investigate metaphase regulation of membrane motility (e.g., Allan and Vale, 1991; Niclas et al., 1996) . We therefore investigated whether BFA-induced membrane tubule formation was similarly regulated within the context of the cell cycle by comparing the levels of membrane tubule formation in metaphase cytosol versus interphase cytosol.
Interphase extracts were made by activating a metaphasearrested extract with Ca 2ϩ in the presence of cycloheximide, which results in a release of the metaphase block and drives the extract into an interphase state. Metaphase-arrested extracts were mock activated (see MATERIALS AND METH-ODS). The cell cycle status of these respective extracts was confirmed by assaying the level of histone H1 phosphorylation (Robertson and Allan, unpublished data) . Histone H1 is a substrate for the mitotic kinase p34cdc2 and can therefore be used to elucidate the level of mitotic kinase activity in an extract (Murray, 1991; Allan, 1998) .
First, we established that substituting metaphase for interphase cytosol had no effect on the ability of BFA to interfere with the membrane binding of ␤-COP (Robertson and Allan, unpublished data) . We then used VE-DIC to monitor whether BFA tubules formed in the presence of metaphase cytosol. Initial observations revealed that substantially fewer tubules were extended in metaphase cytosol, but on closer inspection it was clear that almost all such tubules were extending via attachment to cytoplasmic dynein-driven gliding microtubules (which are seen far more frequently in metaphase compared with interphase cytosols) and were not due to membrane-associated micro- tubule motor activity. To simplify analysis of membrane tubule extension by ensuring that only genuine membrane motor activity was counted, cytoplasmic dynein activity was inhibited by including 40 M sodium orthovanadate, a treatment that did not affect tubule formation in interphase cytosol ( Figure 8A ). Under these conditions it was found that the formation of BFA-induced tubular membrane networks was not supported in metaphase cytosol ( Figure 8A ).
The Membrane Binding of the ϳ130-and ϳ100-kDa
H1 Antigens Is Not Altered as a Result of Incubation in Metaphase Cytosol
There are three possible mechanisms by which the microtubule motor-driven motility of the BFA-induced membrane tubules could be inhibited in metaphase. First, the binding of the motor to the membrane may be controlled directly, so that inhibition of tubule movement corresponds to the motor becoming detached from the membrane. Second, motor binding may remain constant, whereas the ATPase activity of the bound motor is down-regulated. Finally, the microtubule may be modified in some way so that the motor can no longer move along its surface. We therefore tested what happened to the two candidate motors for BFA-induced membrane tubule formation when rat liver Golgi membranes were incubated in interphase cytosol ( Figure 8B , lanes 1 and 4), metaphase cytosol ( Figure 8B , lanes 2 and 5), or buffer ( Figure 8B , lanes 3 and 6) and then pelleted by centrifugation through a sucrose cushion. Immunoblotting with an antibody against a Golgi resident protein, GM130, demonstrated that equal amounts of rat liver Golgi membranes were recovered under all conditions (Figure 8 , lanes 4 -6), with the maximum variation in band intensity being 4.4%.
Immunoblotting with the H1 antibody also revealed only small differences in the amount of the ϳ130-and ϳ100-kDa antigens attached to the membranes after incubation in either cytosol ( Figure 8B , compare lanes 1 and 2). Analysis of band intensity revealed a ϳ25% reduction of ϳ130-kDa motor and an 8% reduction in ϳ100-kDa motor binding in metaphase cytosol compared with interphase cytosol. Given that there the amount of membrane-associated ϳ130-and ϳ100 kDa antigens remained broadly similar, whereas membrane motility was reduced by up to ϳ1700%, it is therefore unlikely that an inhibition of membrane binding is the regulatory mechanism in metaphase.
DISCUSSION
Treatment of living cells with BFA results in the formation of a variety of membrane tubules, including those that move out from the Golgi apparatus and fuse with the ER (Lippincott-Schwartz et al., 1989 Sciaky et al., 1997) and those that extend from the TGN and early endosome, which then fuse with each other Wood et al., 1991) . Although in vivo studies have established a role for microtubule motor protein activity in BFA tubule extension (Lippincott-Schwartz et al., 1990 , 1991 Wood et al., 1991; Reaves and Banting, 1992) , they do not easily allow a more detailed analysis of the properties and regulation of the motor protein involved. In this study, therefore, we have reconstituted BFA-induced membrane tubule formation in vitro in an assay that permits the observation of motor protein activity, coupled with a correlative biochemical analysis.
We have shown that when rat liver Golgi membranes are incubated in interphase Xenopus egg cytosol in the presence of BFA, an intricate network of interconnected membrane tubules is formed. One notable feature of the in vitro BFA tubules is that they contain markers for the Golgi stack, TGN, and early endosomes, suggesting that the membrane fusion events occuring in vitro have a broader specificity than those seen in studies in vivo. This may reflect the fact that these compartments may be in closer contact within the membrane aggregates in the Golgi fraction than they would normally be within the cell. However, it is also possible that there is a low level of Golgi stack-TGN-early endosome fusion that occurs in vivo in the presence of BFA that has gone unnoticed. This might not be surprising given that toxins such as Shiga toxin are able to traffic from the cell surface back to the ER, via the endosome and Golgi apparatus (e.g., Johannes et al., 1997) .
Although the in vitro BFA networks contain a mixture of Golgi stack, TGN, and early endosomal markers, there are a number of features of both our results and those of others that, taken together, strongly suggest that we are looking at the motor activity that drives tubule extension from the Golgi stack, rather than from the TGN or endosomes. First, H1 inhibits the redistribution of the medial Golgi marker mannosidase II in vivo (Lippincott-Schwartz et al., 1995) , and the same reagent blocks BFA tubule formation in our assay. Second, we have found that the function-blocking anti-uKHC antibody SUK 4 does not inhibit tubule motility in vitro. Also, abrogating kinesin function in vivo using a variety of approaches, including the generation of null uKHC mice (Tanaka et al., 1998) , antisense suppression of uKHC expression (Feiguin et al., 1994) , and expression of uKHC ATPase-defective mutants (Nakata and Hirokawa, 1995) , all have no effect on the redistribution of Golgi stack markers to the ER after BFA treatment. Importantly, KHC antisense suppression did inhibit the formation of endosomal and TGN-derived BFA tubules (Feiguin et al., 1994) . The same approaches (Feiguin et al., 1994; Nakata and Hirokawa, 1995; Tanaka et al., 1998; Wubbolts et al., 1999) (reviewed in Lane and Allan, 1998) and that of SUK 4 microinjection (Tuma et al., 1998) also all resulted in an inhibition of plus end-directed lysosome and/or late endosome movement. It seems likely, therefore, that although conventional kinesin moves endocytic organelles, and possibly TGN elements, it does not drive Golgi-to-ER traffic. The latter transport step is driven instead by a motor that is inhibited by H1, and we think it highly likely that we have reconstituted this motile event in vitro.
Membrane tubule networks have also been seen previously to form from these rat liver membranes in the absence of BFA (Allan and Vale, 1994) . We have presented evidence that strongly suggests that the two types of membrane networks are different, based on morphological criteria and immunofluorescence data (Figure 2) , and that distinct motors drive the motility, based on the rates of movement of the two tubule types and the sensitivity of the motors involved to GTP␥S. The crucial difference that determines whether ball-domain tubules form in the absence of BFA seems to be the method used to prepare the Xenopus egg cytosol. Why this should be is currently completely unclear.
Interestingly, Fullerton et al. (1998) observed similar balldomain tubular networks extending from rat liver Golgi fractions in the presence of rat liver cytosol, but in this situation the H1 antibody inhibits the motility of both membrane tubules and vesicles (Fullerton et al., 1998) , which move four times faster than BFA tubules. It is, of course, possible that the antibody is inhibiting the same motor on both ball-domain and BFA tubules but that the different cytosolic conditions result in differences in motor behavior. The other more likely possibility, supported by the biochemical data presented here, is that H1 recognizes and inhibits a number of active motor proteins (at least two). Another function-blocking antibody raised against conventional kinesin, the HD antibody (Rodionov et al., 1991) , has since been found to inhibit other KLPs (Wright et al., 1993; Lombillo et al., 1995) , and recent evidence suggests that the HD antibody also inhibits kinesin II (Tuma et al., 1998) .
The H1 antibody was raised against bovine brain kinesin ( Bloom et al., 1988) and recognizes bacterially expressed rat kinesin heavy chain head domain (Robertson and Allan, unpublished data) . However, the H1 antigen in the Golgi motor fraction that migrates with a similar mobility to that of uKHC surprisingly did not bind to microtubules under conditions of ATP depletion ( Figure 6 ). Moreover, uKHC immunoprecipitated from the Golgi motor fraction was also not recognized by H1 ( Figure 5 ). This suggests that the ϳ124-kDa protein that H1 recognizes in these fractions is a nonmotor protein, which just happens to comigrate with conventional kinesin. Two formal possiblities are that H1 only reacts with a post-translationally modified form of uKHC or with one of the other identified KHC isoforms (all neuronally expressed). We think the former is unlikely based on our experiments using both a polyclonal antiuKHC and the SUK 4 monoclonal anti-uKHC (Figures 5-7) , and the latter possibility was ruled out using an affinitypurified antibody to nKHC (Niclas et al., 1994) .
The fact that pretreating the rat liver Golgi membranes with H1 inhibits BFA-induced membrane tubule formation in Xenopus egg cytosol implies that the motor responsible is an active rat motor. H1 recognizes two bands in a motor fraction prepared from rat liver Golgi membranes, which both behave like a number of kinesin-like proteins in a biochemical assay and which migrate at ϳ100 and ϳ130 kDa. The smaller of these two polypeptides also comigrates with a band that is labeled by an antibody raised against a conserved sequence in the kinesin family motor domain (anti-HIPYR; Sawin et al., 1992) . These results suggest that either the ϳ130-or ϳ100-kDa antigen, and not conventional kinesin, is the motor responsible for driving membrane tubule formation as a result of BFA treatment in vitro. This is supported by the observation that the SUK 4 anti-kinesin heavy chain monoclonal antibody does not inhibit BFA-induced membrane tubule formation in our assay, whereas it does inhibit plus enddirected ER movement under similar experimental conditions (Lane and Allan, 1999) .
Three KLPs have been implicated in Golgi membrane dynamics so far: Rabkinesin 6 (Echard et al., 1998) , kinesin II (Le Yang and Goldstein, 1998) , and KIF1C (Dorner et al., 1998) have all been localized to the Golgi apparatus or associated membranes (either by immunofluoresence or by immunoelectron microscopy). Overexpression of Rabkinesin 6 causes the fragmentation of the Golgi apparatus (Echard et al., 1998) , whereas overexpression of an inactive form of KIF1C appears to inhibit BFA-induced Golgi redistribution (Dorner et al., 1998) . KIF3C (Yang and Goldstein, 1998) and Xklp3 (Le , both of which are members of the kinesin II family, have also been localized to the Golgi apparatus. However, after BFA treatment, Xklp3 was localized to dispersed vesicles positive for the KDEL receptor. These structures do not redistribute to the ER after BFA treatment and are thought to represent a recycling compartment between the ER and Golgi apparatus . All of these proteins (kinesin II/Xklp3/KIF3C, Rabkinesin 6, and KIF1C) together with conventional kinesin migrate at different molecular masses to the ϳ130-kDa motor that we have now identified using the H1 monoclonal antibody, which suggests that at least five different kinesin family members could be involved in the maintenance of normal Golgi structure and function. The ϳ100-kDa motor has a molecular mass very similar to that of Rabkinesin 6, but a number of features strongly suggest that it is a distinct protein. First, bacterially expressed and baculovirus-expressed Rabkinesin 6 is not recognized by H1 (Goud, personal communication) . Second, the Rabkinesin 6 sequence possesses a good LAGSE consensus sequence, but not a HIPYR sequence; in contrast, the ϳ100-kDa motor described here comigrates with a band that labels with anti-HIPYR but not anti-LAGSE. Clearly, the way forward is to obtain the sequences of both the ϳ100-and ϳ130-kDa motors.
So why are so many plus end-directed motors required within the same organelle? The key to this question could lie in the organization of the microtubule array in animal cells. Microtubules are oriented with their plus ends outermost and their minus ends at the microtubule-organizing center, which is located at the center of the cell, near the nucleus. In interphase, the Golgi apparatus is typically clustered around the microtubule-organizing center, and its position is thought to be maintained by the minus end-directed motor cytoplasmic dynein (Burkhardt et al., 1997; Presley et al., 1997; Lane and Allan, 1998) . Microtubule-mediated transport from the Golgi apparatus to more peripheral intracellular sites would therefore require the action of a plus end-directed motor protein. It is likely that a number of distinct transport steps originate from the Golgi apparatus and are directed toward the cell periphery (including transport from the Golgi to the ER, TGN to the plasma membrane, and TGN to the endocytic pathway). Bearing in mind the polar organization of the Golgi apparatus, Golgi-to-ER transport may consist of more than one transport process with, for example, transport from the cis-Golgi to the ER being distinct from transport from the medial-or trans-Golgi to the ER. The existence of these multiple transport steps may well explain the presence of multiple KLPs on the Golgi apparatus, with each motor being responsible for a particular transport process, thus permitting the differential regulation of each motor.
The regulation of motors at various stages of the cell cycle is of particular interest when considering the Golgi apparatus, because of the dramatic change in Golgi morphology that occurs during cell division. During the transition from interphase to mitosis, the Golgi apparatus fragments and vesiculates to become scattered throughout the cell (Robbins and Gonatas, 1964; Lucocq and Warren, 1987) , thus ensuring an even distribution of Golgi components between the two daughter cells. Given that the Golgi apparatus interacts readily with microtubules in interphase (Rogalski and Singer, 1984) , it is possible that an inhibition of microtubule-based Golgi motility during mitosis could aid mitotic Golgi redistribution. Indeed, in experiments using the expression of N-acetyl glucosamine transferase I (a resident Golgi apparatus enzyme) tagged with green fluorescent protein as a marker for the Golgi apparatus in vivo, it has been shown that mitotic Golgi fragments are actively scattered during prophase and prometaphase and are able to remain attached to microtubules but cannot move along them during metaphase (Shima et al., 1997 (Shima et al., , 1998 ). It would be surprising then if metaphase Xenopus egg cytosol did support BFA-induced membrane tubule formation.
There are three basic models for how motor-dependent organelle movement might be regulated. First, the binding of motor to its cargo may be modulated, so that organelle movement is inhibited by the motor responsible becoming detached from the membrane. This appears to be the case for the inhibition of cytoplasmic dynein-driven ER movement in metaphase Xenopus egg cytosol (Allan and Vale, 1991; Niclas et al., 1996) . Second, motor binding may remain constant while the ATPase activity of the bound motor is regulated. Third, the microtubule may be modified in some way so that the motor can no longer move along its surface (e.g., Bulinski et al., 1997 ). The fact that the level of membraneassociated ϳ130-and ϳ100-kDa motors differs little between interphase and metaphase cytosols suggests that regulation is via one of the latter two mechanisms.
